These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24746085)

  • 1. [Surveillance and diagnostic values of ultrasound, computed tomography and magnetic resonance imaging follow-ups in malignant transformation of cirrhotic nodules].
    Ji J; Yang H; Wang Z; Lu C; Hui J
    Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):368-71. PubMed ID: 24746085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
    Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
    PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.
    Lin MT; Chen CL; Wang CC; Cheng YF; Eng HL; Wang JH; Chiu KW; Lee CM; Hu TH
    J Gastroenterol Hepatol; 2011 Apr; 26(4):745-50. PubMed ID: 21418303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].
    De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R
    Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging--a case report.
    Krinsky GA; Theise ND; Rofsky NM; Mizrachi H; Tepperman LW; Weinreb JC
    Radiology; 1998 Nov; 209(2):461-4. PubMed ID: 9807574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
    Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
    Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
    Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
    Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound-detected liver nodules.
    Franzè MS; Bottari A; Caloggero S; Pitrone A; Barbera A; Lembo T; Caccamo G; Cacciola I; Maimone S; Alibrandi A; Pitrone C; Squadrito G; Raimondo G; Saitta C
    Intern Emerg Med; 2021 Jun; 16(4):949-955. PubMed ID: 33111165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis.
    Iavarone M; Manini MA; Sangiovanni A; Fraquelli M; Forzenigo LV; Di Tommaso L; Aghemo A; Roncalli M; Ronchi G; Colombo M
    Dig Liver Dis; 2013 Jan; 45(1):43-9. PubMed ID: 23022425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
    Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization.
    Khalili K; Kim TK; Jang HJ; Haider MA; Khan L; Guindi M; Sherman M
    J Hepatol; 2011 Apr; 54(4):723-8. PubMed ID: 21156219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up.
    Furlan A; Marin D; Agnello F; Di Martino M; Di Marco V; Lagalla R; Catalano C; Brancatelli G
    J Comput Assist Tomogr; 2012; 36(1):20-5. PubMed ID: 22261766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
    Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
    Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
    Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
    Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance and early diagnosis of hepatocellular carcinoma.
    Lencioni R
    Dig Liver Dis; 2010 Jul; 42 Suppl 3():S223-7. PubMed ID: 20547307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.